Steven Truong ’20 named 2025 Knight-Hennessy Scholar
The prestigious fellowship, which honors independence of thought, purposeful leadership, and civic mindset, funds graduate studies at Stanford University.
Cellular traffic congestion in chronic diseases suggests new therapeutic targets
Chronic diseases like diabetes are prevalent, costly, and challenging to treat. A common denominator driving them may be a promising new therapeutic target.
MIT-led team receives funding to pursue new treatments for metabolic disease
Awarded $65.67 million from ARPA-H, the researchers will work to develop ingestible capsules that deliver mRNA and electric stimuli to treat metabolic disorders such as diabetes.
Computational model helps with diabetes drug design
Researchers can use the model to predict how engineered forms of insulin would perform in human patients, making it easier to bring these drugs to clinical trials.
An implantable device could enable injection-free control of diabetes
The device contains encapsulated cells that produce insulin, plus a tiny oxygen-producing factory that keeps the cells healthy.
Providing new pathways for neuroscience research and education
Payton Dupuis finds new scientific interests and career opportunities through MIT summer research program in biology.
Design prevents buildup of scar tissue around medical implants
A new device, which doesn’t rely on immunosuppressing drugs, may assist efforts to develop an artificial pancreas to treat diabetes.
Amy Moran-Thomas receives the Edgerton Faculty Achievement Award
The MIT anthropologist is recognized for interdisciplinary work on health, climate, and equity.
On planetary change and human health
MIT anthropologist Amy Moran-Thomas reflects on the deep connection between planetary and human well-being.
“Living drug factories” might treat diabetes and other diseases
Chemical engineers have developed a way to protect transplanted drug-producing cells from immune system rejection.
Mathematical model could lead to better treatment for diabetes
A new model can predict which types of glucose-responsive insulin will work in humans and animals.
Health care innovators strive to make a difference
A week of learning with MIT Bootcamps sparked ideas that Jal Panchal and Maria Hahn are taking forward to solve problems in health care.
Hydration sensor could improve dialysis
Noninvasive device could benefit patients with kidney disease, congestive heart failure, or dehydration.
Chemists discover structure of glucagon fibrils
Study may be a step toward shelf-stable versions of the hormone, which is used to control diabetes.
A better way to encapsulate islet cells for diabetes treatment
Crystallized drug prevents immune system rejection of transplanted pancreatic islet cells.